{"component": "definition", "props": {"groups": [{"snippet": "means the determination of the value of the consolidated assets of a Person on the basis of the amount which may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going concern basis to an interested buyer who is willing to purchase under ordinary selling conditions in an arm\u2019s length transaction.", "snippet_links": [{"key": "the-value", "type": "clause", "offset": [27, 36]}, {"key": "consolidated-assets", "type": "clause", "offset": [44, 63]}, {"key": "a-person", "type": "definition", "offset": [67, 75]}, {"key": "basis-of", "type": "clause", "offset": [83, 91]}, {"key": "willing-seller", "type": "definition", "offset": [130, 144]}, {"key": "reasonable-time", "type": "clause", "offset": [154, 169]}, {"key": "sale-of", "type": "clause", "offset": [192, 199]}, {"key": "market-value", "type": "definition", "offset": [215, 227]}, {"key": "going-concern-basis", "type": "definition", "offset": [233, 252]}], "size": 117, "samples": [{"hash": "6f0msQaZMCG", "uri": "/contracts/6f0msQaZMCG#fair-valuation", "label": "Note Issuance and Purchase Agreement (Enova International, Inc.)", "score": 37.3066392882, "published": true}, {"hash": "171PXCPEb0n", "uri": "/contracts/171PXCPEb0n#fair-valuation", "label": "Note Issuance and Purchase Agreement (Enova International, Inc.)", "score": 37.3066392882, "published": true}, {"hash": "1L2zxykQM55", "uri": "/contracts/1L2zxykQM55#fair-valuation", "label": "Credit Agreement (Eton Pharmaceuticals, Inc.)", "score": 37.2847366333, "published": true}], "hash": "be67e920a67ad025c147668cbf085c68", "id": 1}, {"snippet": "means the aggregate amount for which the assets of an entity would change hands between an interested purchaser and a seller in an arm\u2019s length transaction, where both parties are aware of all relevant facts and neither party is under any compulsion to act, with reasonable promptness, not to exceed one year.", "snippet_links": [{"key": "aggregate-amount", "type": "clause", "offset": [10, 26]}, {"key": "the-assets", "type": "clause", "offset": [37, 47]}, {"key": "interested-purchaser", "type": "definition", "offset": [91, 111]}, {"key": "parties-are", "type": "clause", "offset": [168, 179]}, {"key": "relevant-facts", "type": "clause", "offset": [193, 207]}, {"key": "neither-party", "type": "definition", "offset": [212, 225]}, {"key": "to-act", "type": "definition", "offset": [250, 256]}, {"key": "reasonable-promptness", "type": "definition", "offset": [263, 284]}, {"key": "not-to-exceed", "type": "definition", "offset": [286, 299]}, {"key": "one-year", "type": "clause", "offset": [300, 308]}], "size": 16, "samples": [{"hash": "xxf6O73iGb", "uri": "https://www.sec.gov/Archives/edgar/data/1418919/000095013508004267/filename8.htm", "label": "CPEX Pharmaceuticals, Inc.", "score": 5.0, "published": false}, {"hash": "hN4WSfj2f4D", "uri": "https://www.sec.gov/Archives/edgar/data/1563665/000114420413051834/v355263_ex99x1.htm", "label": "Harvard Apparatus Regenerative Technology, Inc.", "score": 4.7180013657, "published": false}, {"hash": "bIc2GF2t6Yx", "uri": "https://www.sec.gov/Archives/edgar/data/1563665/000114420413042225/v351056_ex99x1.htm", "label": "Harvard Apparatus Regenerative Technology, Inc.", "score": 4.578371048, "published": false}], "hash": "e8013559a9e6391c21f4c9e582fd4144", "id": 2}, {"snippet": "of any assets means the amount realizable within a reasonable time, either through collection or sale, of such assets at their regular market value, which is the amount obtainable by a capable and diligent businessman from an interested buyer willing to purchase such assets within a reasonable time under ordinary circumstances; and (2) the term \u201cdebts\u201d includes any legal liability whether matured or unmatured, liquidated or unliquidated, absolute, fixed, or contingent.", "snippet_links": [{"key": "reasonable-time", "type": "clause", "offset": [51, 66]}, {"key": "market-value", "type": "definition", "offset": [135, 147]}, {"key": "the-term", "type": "definition", "offset": [338, 346]}, {"key": "legal-liability", "type": "clause", "offset": [368, 383]}], "size": 11, "samples": [{"hash": "8xBeWEeaUzy", "uri": "/contracts/8xBeWEeaUzy#fair-valuation", "label": "Syndicated Facility Agreement (Resmed Inc)", "score": 29.2956886292, "published": true}, {"hash": "6cYQw5nRioW", "uri": "/contracts/6cYQw5nRioW#fair-valuation", "label": "Credit Agreement (Resmed Inc)", "score": 28.0308017731, "published": true}, {"hash": "3HxSd5LPT2O", "uri": "/contracts/3HxSd5LPT2O#fair-valuation", "label": "Credit Agreement (Resmed Inc)", "score": 27.2559890747, "published": true}], "hash": "9ac773ce79bc6e7e6dfe6fac3e9d16e2", "id": 3}, {"snippet": "means the determination of the value of the consolidated assets of a Person on the basis of the amount which may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going concern basis to an interested buyer who is willing to purchase under ordinary selling conditions in an arm\u2019s length transaction. FATCA means Sections 1471 through 1474 of the IRC and any current or future regulations thereunder or official interpretations thereof. FD&C Act means the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. \u00a7\u00a7 301 et seq., as amended.", "snippet_links": [{"key": "the-value", "type": "clause", "offset": [27, 36]}, {"key": "consolidated-assets", "type": "clause", "offset": [44, 63]}, {"key": "a-person", "type": "definition", "offset": [67, 75]}, {"key": "basis-of", "type": "clause", "offset": [83, 91]}, {"key": "willing-seller", "type": "definition", "offset": [130, 144]}, {"key": "reasonable-time", "type": "clause", "offset": [154, 169]}, {"key": "sale-of", "type": "clause", "offset": [192, 199]}, {"key": "market-value", "type": "definition", "offset": [215, 227]}, {"key": "going-concern-basis", "type": "definition", "offset": [233, 252]}, {"key": "fatca-means", "type": "clause", "offset": [369, 380]}, {"key": "future-regulations", "type": "clause", "offset": [438, 456]}, {"key": "fdc-act", "type": "definition", "offset": [505, 513]}, {"key": "as-amended", "type": "definition", "offset": [588, 598]}], "size": 10, "samples": [{"hash": "hUBl6PXph6k", "uri": "/contracts/hUBl6PXph6k#fair-valuation", "label": "Commitment Letter (New Misonix, Inc.)", "score": 30.5058174133, "published": true}, {"hash": "2uA7ACI7Y9R", "uri": "/contracts/2uA7ACI7Y9R#fair-valuation", "label": "Credit Agreement (Hooper Holmes Inc)", "score": 28.3593425751, "published": true}, {"hash": "9za1BvWqEVK", "uri": "/contracts/9za1BvWqEVK#fair-valuation", "label": "Credit Agreement (SWK Holdings Corp)", "score": 26.2320327759, "published": true}], "hash": "0dd848801940c74398ff34d39faf17ec", "id": 4}, {"snippet": "means the aggregate amount for which assets of an entity would change hands between an independent willing buyer and an independent willing seller, in an arm\u2019s length transaction, where both parties are aware of all relevant facts and neither party is under any compulsion to act.", "snippet_links": [{"key": "aggregate-amount", "type": "clause", "offset": [10, 26]}, {"key": "an-independent", "type": "clause", "offset": [84, 98]}, {"key": "willing-seller", "type": "definition", "offset": [132, 146]}, {"key": "parties-are", "type": "clause", "offset": [191, 202]}, {"key": "relevant-facts", "type": "clause", "offset": [216, 230]}, {"key": "neither-party", "type": "definition", "offset": [235, 248]}, {"key": "to-act", "type": "definition", "offset": [273, 279]}], "size": 9, "samples": [{"hash": "6y9fjS2cG7x", "uri": "/contracts/6y9fjS2cG7x#fair-valuation", "label": "Membership Interest Purchase Agreement (MSA Safety Inc)", "score": 34.013004303, "published": true}, {"hash": "coFSRgFRyja", "uri": "/contracts/coFSRgFRyja#fair-valuation", "label": "Membership Interest Purchase Agreement (ITT Inc.)", "score": 32.4962348938, "published": true}, {"hash": "igcL79J2uts", "uri": "https://www.itt.com/itt/Media/itt/ITTSite/Investors/ITT-Form-8-K-w-Exhibits-2021-07-01.pdf", "label": "www.itt.com", "score": 10.7481174469, "published": false}], "hash": "83635185b19fafbb5a44b10a3b55cd69", "id": 5}, {"snippet": "is intended to mean that value which can be obtained if the assets are sold within a reasonable time in arm's-length transactions in an existing and not theoretical market.", "snippet_links": [{"key": "the-assets", "type": "clause", "offset": [56, 66]}, {"key": "reasonable-time", "type": "clause", "offset": [85, 100]}], "size": 9, "samples": [{"hash": "jb5jdSDR33q", "uri": "/contracts/jb5jdSDR33q#fair-valuation", "label": "Loan Agreement (Armor Holdings Inc)", "score": 18.0, "published": true}, {"hash": "8oWvSm9JWr5", "uri": "/contracts/8oWvSm9JWr5#fair-valuation", "label": "Loan Agreement (American Technical Ceramics Corp)", "score": 18.0, "published": true}, {"hash": "78r85YXGzOj", "uri": "/contracts/78r85YXGzOj#fair-valuation", "label": "Loan Agreement (Armor Holdings Inc)", "score": 18.0, "published": true}], "hash": "73ea6def57eb05052901f879d479a473", "id": 6}, {"snippet": "means, (a) if the Common Stock is then listed and trading on a domestic securities exchange, (x) the volume weighted average of the closing sales prices of the Common Stock for such day on all domestic securities exchanges on which the Common Stock may at the time be listed, or (y) if there have been no sales of the Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices for the Common Stock on all such exchanges at the end of such day; or (b) if at the applicable time of determination, the Common Stock is not listed on any domestic securities exchange, the \u201cFair Valuation\u201d of the Common Stock shall be the fair market value per share as determined by a nationally recognized investment banking, accounting or valuation firm selected by the Company and reasonably acceptable to Payee. The determination of such firm shall be final and conclusive, and the fees and expenses of such valuation firm shall be borne by the Company unless the fair market value per share of the Common Stock, as determined by such firm is US $0.60 (fifty cents US) or more, in which case the fees and expenses of such valuation firm shall be borne by Payee.", "snippet_links": [{"key": "the-common-stock", "type": "clause", "offset": [14, 30]}, {"key": "securities-exchange", "type": "definition", "offset": [72, 91]}, {"key": "volume-weighted-average", "type": "definition", "offset": [101, 124]}, {"key": "the-closing", "type": "definition", "offset": [128, 139]}, {"key": "sales-prices", "type": "clause", "offset": [140, 152]}, {"key": "at-the-time", "type": "clause", "offset": [253, 264]}, {"key": "no-sales", "type": "clause", "offset": [302, 310]}, {"key": "stock-on", "type": "definition", "offset": [325, 333]}, {"key": "highest-bid", "type": "definition", "offset": [388, 399]}, {"key": "at-the-end-of", "type": "clause", "offset": [467, 480]}, {"key": "time-of-determination", "type": "definition", "offset": [519, 540]}, {"key": "stock-shall", "type": "definition", "offset": [645, 656]}, {"key": "the-fair-market-value", "type": "clause", "offset": [660, 681]}, {"key": "nationally-recognized", "type": "definition", "offset": [711, 732]}, {"key": "investment-banking", "type": "definition", "offset": [733, 751]}, {"key": "accounting-or-valuation-firm", "type": "clause", "offset": [753, 781]}, {"key": "by-the-company", "type": "clause", "offset": [791, 805]}, {"key": "the-determination-of", "type": "definition", "offset": [842, 862]}, {"key": "final-and-conclusive", "type": "clause", "offset": [882, 902]}, {"key": "expenses-of", "type": "clause", "offset": [921, 932]}, {"key": "fair-market-value-per-share-of", "type": "clause", "offset": [994, 1024]}], "size": 6, "samples": [{"hash": "7wVwF4SM1V7", "uri": "https://www.sec.gov/Archives/edgar/data/1706524/000168316820004375/urban_ex1001.htm", "label": "Convertible Promissory Note (Urban-Gro, Inc.)", "score": 19.96235466, "published": false}, {"hash": "jXbnh8t1u5m", "uri": "https://www.sec.gov/Archives/edgar/data/1706524/000168316820004100/urban_ex1003.htm", "label": "Convertible Promissory Note (Urban-Gro, Inc.)", "score": 19.8993835449, "published": false}, {"hash": "1RdxR76GeJX", "uri": "https://www.sec.gov/Archives/edgar/data/1706524/000168316820004100/urban_ex1002.htm", "label": "Convertible Promissory Note (Urban-Gro, Inc.)", "score": 19.8993835449, "published": false}], "hash": "fa4297864f2b90740b599c6317038e64", "id": 7}, {"snippet": "means in respect of any entity the value of the consolidated assets of such entity on the basis of the amount which may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going concern basis to an interested buyer who is willing to purchase under ordinary selling conditions in an arm\u2019s-length transaction.", "snippet_links": [{"key": "in-respect-of", "type": "clause", "offset": [6, 19]}, {"key": "the-value", "type": "clause", "offset": [31, 40]}, {"key": "consolidated-assets", "type": "clause", "offset": [48, 67]}, {"key": "basis-of", "type": "clause", "offset": [90, 98]}, {"key": "willing-seller", "type": "definition", "offset": [137, 151]}, {"key": "reasonable-time", "type": "clause", "offset": [161, 176]}, {"key": "sale-of", "type": "clause", "offset": [199, 206]}, {"key": "market-value", "type": "definition", "offset": [222, 234]}, {"key": "going-concern-basis", "type": "definition", "offset": [240, 259]}], "size": 6, "samples": [{"hash": "hUDfNZBVyT1", "uri": "/contracts/hUDfNZBVyT1#fair-valuation", "label": "Amendment to Indenture (Enova International, Inc.)", "score": 29.1533203125, "published": true}, {"hash": "9AXqL4BUhIu", "uri": "https://www.sec.gov/Archives/edgar/data/1529864/000156459018003222/enva-ex49_120.htm", "label": "Enova International, Inc.", "score": 13.1533193588, "published": false}, {"hash": "imXE4c8Sz6c", "uri": "https://www.sec.gov/Archives/edgar/data/1529864/000156459016020548/enva-ex101_9.htm", "label": "Enova International, Inc.", "score": 11.4476385117, "published": false}], "hash": "304ba6e10ace1e8ea7268cec13a04389", "id": 8}, {"snippet": "means the determination of the value of the consolidated assets of a Person on the basis of the amount which may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going concern basis to an interested buyer who is willing to purchase under ordinary selling conditions in an arm\u2019s length transaction. FATCA means Sections 1471 through 1474 of the IRC, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the IRC and any fiscal, Tax or regulatory legislation, rules or official practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of Sections 1471 through 1474 of the IRC and any current or future regulations promulgated thereunder. FD&C Act means the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. \u00a7\u00a7 301 et seq., as amended, and all applicable regulations or guidance promulgated by the FDA. FDA means the Food and Drug Administration of the United States of America.", "snippet_links": [{"key": "the-value", "type": "clause", "offset": [27, 36]}, {"key": "consolidated-assets", "type": "clause", "offset": [44, 63]}, {"key": "a-person", "type": "definition", "offset": [67, 75]}, {"key": "basis-of", "type": "clause", "offset": [83, 91]}, {"key": "willing-seller", "type": "definition", "offset": [130, 144]}, {"key": "reasonable-time", "type": "clause", "offset": [154, 169]}, {"key": "sale-of", "type": "clause", "offset": [192, 199]}, {"key": "market-value", "type": "definition", "offset": [215, 227]}, {"key": "going-concern-basis", "type": "definition", "offset": [233, 252]}, {"key": "fatca-means", "type": "clause", "offset": [369, 380]}, {"key": "date-of-this-agreement", "type": "definition", "offset": [430, 452]}, {"key": "comply-with", "type": "definition", "offset": [558, 569]}, {"key": "future-regulations", "type": "clause", "offset": [590, 608]}, {"key": "entered-into", "type": "clause", "offset": [661, 673]}, {"key": "pursuant-to-section", "type": "definition", "offset": [674, 693]}, {"key": "intergovernmental-agreement", "type": "clause", "offset": [815, 842]}, {"key": "in-connection-with", "type": "clause", "offset": [856, 874]}, {"key": "fdc-act", "type": "definition", "offset": [997, 1005]}, {"key": "as-amended", "type": "definition", "offset": [1080, 1090]}, {"key": "applicable-regulations", "type": "clause", "offset": [1100, 1122]}, {"key": "the-fda", "type": "clause", "offset": [1150, 1157]}, {"key": "the-united-states-of-america", "type": "clause", "offset": [1205, 1233]}], "size": 5, "samples": [{"hash": "4jTu6ie0i8P", "uri": "/contracts/4jTu6ie0i8P#fair-valuation", "label": "Credit Agreement (Acer Therapeutics Inc.)", "score": 34.3661880493, "published": true}, {"hash": "mQRBbE3SnP", "uri": "/contracts/mQRBbE3SnP#fair-valuation", "label": "Credit Agreement (Acer Therapeutics Inc.)", "score": 34.081451416, "published": true}, {"hash": "2byPzp6JQZT", "uri": "/contracts/2byPzp6JQZT#fair-valuation", "label": "Credit Agreement (Acer Therapeutics Inc.)", "score": 33.1779594421, "published": true}], "hash": "4e0e063f6f4301832b7955dc1d5b4038", "id": 9}, {"snippet": "means the determination of the value of the consolidated assets of a Person on the basis of the amount which may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going concern basis to an interested buyer who is willing to purchase under ordinary selling conditions in an arm\u2019s length transaction. FD&C Act means the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. \u00a7\u00a7 301 et seq., as amended. CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. FDA means the Food and Drug Administration of the United States of America.", "snippet_links": [{"key": "the-value", "type": "clause", "offset": [27, 36]}, {"key": "consolidated-assets", "type": "clause", "offset": [44, 63]}, {"key": "a-person", "type": "definition", "offset": [67, 75]}, {"key": "basis-of", "type": "clause", "offset": [83, 91]}, {"key": "willing-seller", "type": "definition", "offset": [130, 144]}, {"key": "reasonable-time", "type": "clause", "offset": [154, 169]}, {"key": "sale-of", "type": "clause", "offset": [192, 199]}, {"key": "market-value", "type": "definition", "offset": [215, 227]}, {"key": "going-concern-basis", "type": "definition", "offset": [233, 252]}, {"key": "fdc-act", "type": "definition", "offset": [369, 377]}, {"key": "as-amended", "type": "definition", "offset": [452, 462]}, {"key": "this-exhibit", "type": "definition", "offset": [484, 496]}, {"key": "request-for-confidential-treatment", "type": "definition", "offset": [528, 562]}, {"key": "the-non", "type": "clause", "offset": [567, 574]}, {"key": "public-information", "type": "clause", "offset": [575, 593]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [614, 652]}, {"key": "the-united-states-of-america", "type": "clause", "offset": [700, 728]}], "size": 4, "samples": [{"hash": "a2yBvdZi1Qt", "uri": "/contracts/a2yBvdZi1Qt#fair-valuation", "label": "Credit Agreement (Aralez Pharmaceuticals Inc.)", "score": 27.0177955627, "published": true}, {"hash": "8RPsRaONvJd", "uri": "/contracts/8RPsRaONvJd#fair-valuation", "label": "Credit Agreement (Aralez Pharmaceuticals Inc.)", "score": 27.0177955627, "published": true}, {"hash": "4TktH83tGhh", "uri": "/contracts/4TktH83tGhh#fair-valuation", "label": "Credit Agreement (Aralez Pharmaceuticals Inc.)", "score": 27.0177955627, "published": true}], "hash": "491058ca11aa44827a7917e8e186856a", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXZmFpci12YWx1YXRpb24jMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means the determination of the value of the consolidated assets of a Person on the basis of the amount which may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going concern basis to an interested buyer who is willing to purchase under ordinary selling conditions in an arm\u2019s length transaction.", "size": 219, "title": "Fair Valuation", "id": "fair-valuation", "examples": ["Each Credit Party is and, after giving effect to the transactions and the Indebtedness contemplated by the Loan Documents, will be solvent and able to meet its obligations and liabilities as they become due, and the assets of the each Credit Party, at a <strong>Fair Valuation</strong>, exceed the total liabilities (including contingent, subordinated, unmatured and unliquidated liabilities) of such Credit Party, and no unreasonably small capital base exists with respect to such Credit Party.", "Such actual costs are referred to as the Annual <strong>Fair Valuation</strong> Vendor Fee and will be calculated at the discounted group rate made available to BISYS clients by the <strong>Fair Valuation</strong> Information Vendors, if applicable.", "Neither Huntington nor the Trusts will be obligated to make any additional payments under the Annual BISYS Fee or the Annual <strong>Fair Valuation</strong> Vendor Fee after the expiration of the thirty (30) day notice period.", "Borrower is and, after giving effect to the transactions and the Indebtedness contemplated by the Loan Documents, will be solvent and able to meet its obligations and liabilities as they become due, and the assets of Borrower, at a <strong>Fair Valuation</strong>, exceed its total liabilities (including contingent, subordinated, unmatured and unliquidated liabilities), and no unreasonably small capital base with which to engage in its business exists with respect to Borrower (on a consolidated basis).", "Borrower is and, after giving effect to the transactions and the incurrence of Indebtedness contemplated by the Loan Documents, will be solvent and able to meet its obligations and liabilities as they become due, and the assets of Borrower, at a <strong>Fair Valuation</strong>, exceed the Total Liabilities (including contingent, subordinated, unmatured and unliquidated liabilities) of Borrower, and no unreasonably small capital base exists with respect to Borrower.", "Borrower is and, after giving effect to the transactions and the Indebtedness contemplated by the Loan Documents, will be solvent and able to meet its obligations and liabilities as they become due, and the assets of Borrower, at a <strong>Fair Valuation</strong>, exceed the total liabilities (including contingent, subordinated, unmatured and unliquidated liabilities) of Borrower, and no unreasonably small capital base with which to engage in its anticipated business exists with respect to Borrower.", "If Subadviser fails to communicate a <strong>Fair Valuation</strong> Event within the timeline outlined in this Section 2(h) of this Agreement that directly results in the Fund having a \u201cmaterial pricing error\u201d (as defined in the Trust\u2019s Pricing Error Policy), Subadviser shall be responsible for any resulting loss incurred by the Trust as a result of a late reported (or non-reported) <strong>Fair Valuation</strong> Event.", "Such reasonable assistance shall include (but is not limited to) verifying pricing and providing <strong>fair valuations</strong> or recommendations for <strong>fair valuations</strong> to the Advisor as a result of a <strong>Fair Valuation</strong> Event, in accordance with the Trust\u2019s valuation policy, on a same day that the <strong>Fair Valuation</strong> Event occurs.", "The <strong>Fair Valuation</strong> Committee of the Trust has approved, or shall approve, each independent pricing vendor and Fair Value Information Vendor to be used by BISYS in rendering fund accounting services, including Fair Value Support Services hereunder.", "The Adviser, following its own <strong>Fair Valuation</strong> policies, will provide assistance to the Manager in determining the fair value of all securities and other investments owned by the Portfolios, and use reasonable efforts to arrange for the provision of valuation information or prices from parties independent of the Adviser with respect to the securities or other investments owned by the Portfolios for which market prices are not readily available."], "related": [["company-valuation", "Company Valuation", "Company Valuation"], ["independent-valuation", "Independent Valuation", "Independent Valuation"], ["fair-salable-value", "Fair salable value", "Fair salable value"], ["fair-value", "Fair Value", "Fair Value"], ["present-fair-salable-value", "Present Fair Salable Value", "Present Fair Salable Value"]], "related_snippets": [], "updated": "2026-04-25T05:28:14+00:00"}, "json": true, "cursor": ""}}